These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 19362986)

  • 1. Waldenström's macroglobulinemia: hyperviscosity syndrome and cryoglobulinemia.
    Stone MJ
    Clin Lymphoma Myeloma; 2009 Mar; 9(1):97-9. PubMed ID: 19362986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of plasmapheresis on hyperviscosity-related retinopathy and retinal hemodynamics in patients with Waldenstrom's macroglobulinemia.
    Menke MN; Feke GT; McMeel JW; Treon SP
    Invest Ophthalmol Vis Sci; 2008 Mar; 49(3):1157-60. PubMed ID: 18326744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ophthalmologic techniques to assess the severity of hyperviscosity syndrome and the effect of plasmapheresis in patients with Waldenström's macroglobulinemia.
    Menke MN; Feke GT; McMeel JW; Treon SP
    Clin Lymphoma Myeloma; 2009 Mar; 9(1):100-3. PubMed ID: 19362987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of plasmapheresis in Waldenström's macroglobulinemia.
    Stone MJ; Bogen SA
    Clin Lymphoma Myeloma Leuk; 2013 Apr; 13(2):238-40. PubMed ID: 23522642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasmapheresis and cold sensitivity of immunoglobulin molecules. I. A study of hyperviscosity, cryoglobulinemia, euglobulinemia and macroglobulinemia vera.
    Waldenström JG; Raiend U
    Acta Med Scand; 1984; 216(5):449-66. PubMed ID: 6441457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Waldenström macroglobulinemia with cryoglobulinemia revealed by amorphous deposits on blood smear.
    Guiheneuf E; Celeste E; Claisse JF; Espanel C
    Int J Hematol; 2013 Sep; 98(3):269-70. PubMed ID: 23893295
    [No Abstract]   [Full Text] [Related]  

  • 7. Cryoglobulins and pyroglobulins: an overview.
    Dammacco F; Miglietta A; Lobreglio G; Bonomo L
    Ric Clin Lab; 1986; 16(2):247-67. PubMed ID: 3097789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence-based focused review of management of hyperviscosity syndrome.
    Stone MJ; Bogen SA
    Blood; 2012 Mar; 119(10):2205-8. PubMed ID: 22147890
    [No Abstract]   [Full Text] [Related]  

  • 9. [An autopsy case of Waldenström's macroglobulinemia with pyroglobulin, cryoglobulin and hyperviscosity syndrome (author's transl)].
    Deura K; Ishii Z; Shimoyama M; Minato K
    Rinsho Ketsueki; 1980 Feb; 21(2):240-50. PubMed ID: 6774129
    [No Abstract]   [Full Text] [Related]  

  • 10. Autoantibody activity in Waldenstrom's macroglobulinemia.
    Stone MJ; Merlini G; Pascual V
    Clin Lymphoma; 2005 Mar; 5(4):225-9. PubMed ID: 15794853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiopulmonary Bypass in the Setting of Waldenström's Macroglobulinemia.
    D'Aloiso BD; Rupchak SS; Gettle KJ; Lima C; Rush RD
    J Extra Corpor Technol; 2018 Jun; 50(2):120-123. PubMed ID: 29921992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of emergency apheresis in the management of plasma cell disorders.
    Kalayoglu-Besisik S
    Transfus Apher Sci; 2018 Feb; 57(1):35-39. PubMed ID: 29477943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenesis and morbidity of autoantibody syndromes in Waldenstrom's macroglobulinemia.
    Stone MJ
    Clin Lymphoma Myeloma Leuk; 2011 Feb; 11(1):157-9. PubMed ID: 21454221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment recommendations in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.
    Gertz MA; Anagnostopoulos A; Anderson K; Branagan AR; Coleman M; Frankel SR; Giralt S; Levine T; Munshi N; Pestronk A; Rajkumar V; Treon SP
    Semin Oncol; 2003 Apr; 30(2):121-6. PubMed ID: 12720120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Letter: Mixed IgM-IgG cryoglobulinemia. A case in a patient with Waldenström's macroglobulinemia].
    Rigo P; de Leval-Rutten F; Salmon J
    Nouv Presse Med; 1973 Nov; 2(39):2603. PubMed ID: 4210370
    [No Abstract]   [Full Text] [Related]  

  • 16. Acute renal failure secondary to severe type I cryoglobulinemia following rituximab therapy for Waldenström's macroglobulinemia.
    Shaikh A; Habermann TM; Fidler ME; Kumar S; Leung N
    Clin Exp Nephrol; 2008 Aug; 12(4):292-295. PubMed ID: 18288560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bilateral, persistent serous macular detachments with Waldenström's macroglobulinemia.
    Pilon AF; Rhee PS; Messner LV
    Optom Vis Sci; 2005 Jul; 82(7):573-8. PubMed ID: 16044069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The value of serum free light chains in a case of Waldenstrom's macroglobulinaemia that produces a type I cryoglobulinaemia.
    Pattenden RJ; Davidson KL; Wenham PR
    Ann Clin Biochem; 2009 Nov; 46(Pt 6):531-2. PubMed ID: 19822697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of therapeutic procedure for Waldenström's macroglobulinemia with hyperviscosity syndrome.
    Ito K; Kawasaki T; Hirano K; Sekiguchi N
    Ther Apher Dial; 2024 Jun; 28(3):417-423. PubMed ID: 38069574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Waldenstrom's macroglobulinemia, a hyperviscosity manifestation of venous stasis retinopathy.
    Feman SS; Stein RS
    Int Ophthalmol; 1981 Aug; 4(1-2):107-12. PubMed ID: 6795138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.